📰 Code Therapeutics News
Page 9 - Code Therapeutics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Code Therapeutics. Real-time updates on events, politics, business and more.
January 9, 2023
RESEARCH TRIANGLE PARK, N.C., Jan. 9, 2023 /PRNewswire/ -- Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated s...
December 9, 2022
Gainers Ambrx Biopharma Inc. (NYSE:AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Brea...
December 8, 2022
/PRNewswire/ -- FinancialNewsMedia.com News Commentary - According to a report from Global Market Insights the Breast Cancer Therapeutics Market size, which...
December 8, 2022
PALM BEACH, Fla., Dec. 8, 2022 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - According to a report from Global Market Insights the Breast Cancer Therapeutics Market size, which exceeded
December 7, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping 75 points on Wednesday. The Dow traded down 0.22% to 33,521.1...
December 6, 2022
06.12.2022 - BOSTON, Dec. 06, 2022 (GLOBE NEWSWIRE) - TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (the “Company”), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced today that it withdrew the Registration ...
November 30, 2022
BOSTON, Nov. 30, 2022 -- TransCode Therapeutics, Inc. , the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced today that it has submitted an... | November 30, 2022
November 10, 2022
PALM BEACH, Fla., Nov. 10, 2022 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - The pancreatic cancer treatment market is fiercely competitive. To maintain the escalating market competition
November 10, 2022
/PRNewswire/ -- FinancialNewsMedia.com News Commentary - The pancreatic cancer treatment market is fiercely competitive. To maintain the escalating market...
November 9, 2022
09.11.2022 - BOSTON, Nov. 09, 2022 (GLOBE NEWSWIRE) - TransCode Therapeutics, Inc. (Nasdaq: RNAZ), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today reported positive preclinical results with its immunotherapy ... Seite 1